| Mon, Oct 26, 2009 | | • | Phase III Trial Expenses For Diabetes Treatments Now Forcing Acquisitions Of Small Cap Biotech Firms: FDA Has "Raised The Bar" For Approval Due To Recent Cardiovascular Issues
Wall Street Transcript (Mon, Oct 26)
| | Fri, Oct 23, 2009 | | • | [$$] Two Top Ideas in Biotech
at Barrons.com (Fri, Oct 23)
| | Thu, Oct 22, 2009 | | • | 7 Stocks With Growth on the Menu
at Motley Fool (Thu, Oct 22)
| | • | The Gift That Keeps on Giving
at Motley Fool (Thu, Oct 22)
| | • | 5 Stock Charts to Watch
at CNBC (Thu, Oct 22)
| | • | New Star Analyst Rankings for Genzyme Corporation
StarMine (Thu, Oct 22)
| | Wed, Oct 21, 2009 | | • | UBS Investment Research Analyst Sees Positive Outlook for Large-Cap Biotechnology
Wall Street Transcript (Wed, Oct 21)
| | • | [$$] Genzyme Third-Quarter Earnings Tumble 87%
at The Wall Street Journal Online (Wed, Oct 21)
| | • | Biotech Stocks: Genzyme slides on outlook; Antigenics plunges
at MarketWatch (Wed, Oct 21)
| | • | Genzyme 3Q profit plunges on facility costs
AP (Wed, Oct 21)
| | • | Genzyme's Q3 net tumbles, guidance lowered
at bizjournals.com (Wed, Oct 21)
| | • | Genzyme Corporation Earnings Call scheduled for 11:00 am ET today
CCBN (Wed, Oct 21)
| | • | Biotech Stocks: Genzyme slides on outlook; Antigenics tanks
at MarketWatch (Wed, Oct 21)
| | • | GENZYME CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, Oct 21)
| | • | Plant shutdown weighs on Genzyme earnings
at MarketWatch (Wed, Oct 21)
| | • | Genzyme Posts Lower Profit, Cuts View
at TheStreet.com (Wed, Oct 21)
| | • | Genzyme Posts Lower Profits, Cuts Guidance
at TheStreet.com (Wed, Oct 21)
| | • | Genzyme Reports Third-Quarter Financial Results
Business Wire (Wed, Oct 21)
| | • | Q3 2009 Genzyme Corporation Earnings Release - Time Not Supplied
CCBN (Wed, Oct 21)
| | • | Matrix Asset Advisors Chief Investment Officer Sees "Opportunistic Large Cap Value" As Current Sweet Spot In Market
Wall Street Transcript (Wed, Oct 21)
| | • | Trading Review for Inovio Biomedical Corp. Issued by InvestorSoup.com
GlobeNewswire (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | Genzyme launches new Gaucher drug trial
at bizjournals.com (Tue, Oct 20)
| | • | TradingMarkets 7 Stocks You Need to Know for Wednesday
TradingMarkets.com (Tue, Oct 20)
| | • | First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease
Business Wire (Tue, Oct 20)
| | • | Immunostimulatory Antibodies Seen As Potential Treatment For Broad Range Of Cancers And Catalyst For Investment Returns By Ladenburg Thalmann Analyst
Wall Street Transcript (Tue, Oct 20)
|
Add GENZ News to My Yahoo!:
 
| |
|
0.11% Nasdaq 
Headlines
